Zhitong Finance App News, Fosun Pharmaceuticals (600196.SH) announced that the company's holding subsidiary Gisme (Wuhan) Pharmaceutical Co., Ltd.'s application for marketing registration of oxaliplatin injections was recently approved by the China Drug Administration.

Zhitongcaijing · 4d ago
Zhitong Finance App News, Fosun Pharmaceuticals (600196.SH) announced that the company's holding subsidiary Gisme (Wuhan) Pharmaceutical Co., Ltd.'s application for marketing registration of oxaliplatin injections was recently approved by the China Drug Administration.